Ironwood Pharmaceuticals Inc Call to Discuss the IW-3718 program Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Ironwood Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Meredith Kaya. You may begin.
Good morning, and thanks for joining us to discuss our 3718 Phase III program. A press release crossed the wire this morning and can be found on our website, www.ironwoodpharma.com.
Today's call includes forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available under the heading Risk Factors in our annual report on Form 10-Q for the quarter ended June 30, 2020, and in our future SEC filings. Our forward-looking statements speak as of today's date, and we undertake no obligation to update such statements.
During this conference call,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
